Meningococcal Conjugates Vaccine - Biotech, Pharma and Life Science Channel

16:05 EDT 29th July 2015 | BioPortfolio

PubMed Articles [2048 Associated PubMed Articles listed on BioPortfolio]

Fabrication of chitosan microspheres using vanillin/TPP dual crosslinkers for protein antigens encapsulation.

Microspheres were prepared from water soluble chitosan using dual vanillin/TPP crosslinkers. Placebo (C1), Bovine serum albumin (BSA) (C2), monovalent tetanus toxoid (TT) (C3) and divalent tetanus (TT...

Chimeric DNA vaccines encoding Eimeria acervulina macrophage migration inhibitory factor (E.MIF) induce partial protection against experimental Eimeria infection.

Chimeric DNA vaccines co-expressing Eimeria acervulina macrophage migration inhibitory factor (E.MIF) and chicken IL-2 (IL-2) or interferon-γ (IFN-γ) were constructed and their efficacies against E....

Chitosan-isoniazid conjugates: Synthesis, evaluation of tuberculostatic activity, biodegradability and toxicity.

Novel water-soluble chitosan-isoniazid conjugates were synthesized by two methods: (1) the carbodiimide method using isoniazid (INH) and N-(2-carboxyethyl)chitosan (CEC), and (2) the reaction between ...

Improvement of emulsifying properties of oat protein isolate-dextran conjugates by glycation.

In order to improve the emulsifying properties of oat protein, oat protein isolate (OPI)-dextran (Dex) conjugates were prepared by glycation reaction. Emulsifying properties of emulsions stabilized by...

Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.

The vaccination rate against hepatitis B virus (HBV) is low in inflammatory bowel disease (IBD) patients. The Consensus from the European Crohn's and Colitis Organisation on opportunistic infections r...

Advances in development of a contraceptive vaccine against human chorionic gonadotropin.

There is continuing need for contraceptives. According to World Health Organization, 210 million pregnancies occur each year, out of which some 80 million are unintended. A vaccine offering privacy an...

107 ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma.

EGFRvIII, a constitutively active EGFR deletion driver mutation, is associated with poor long-term survival in glioblastoma (GB). The investigational vaccine rindopepimut consists of a peptide sequenc...

Community-Based Outbreak of Neisseria meningitidis Serogroup C Infection in Men who Have Sex with Men, New York City, New York, USA, 2010-2013.

In September 2012, the New York City Department of Health and Mental Hygiene identified an outbreak of Neisseria meningitidis serogroup C invasive meningococcal disease among men who have sex with men...

Risk Factors for Serogroup C Meningococcal Disease during Outbreak among Men who Have Sex with Men, New York City, New York, USA.

Risk factors for illness during a serogroup C meningococcal disease outbreak among men who have sex with men in New York City, New York, USA, in 2012-2013 included methamphetamine and cocaine use and ...

Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger.

To inform epidemic response strategies for the African meningitis belt after a meningococcal serogroup A conjugate vaccine was introduced in 2010, we compared the effectiveness and efficiency of menin...

News Articles [2409 Associated News Articles listed on BioPortfolio]

GlaxoSmithKline sees staged roll-out of malaria vaccine

The world's first malaria vaccine, which won a green light last week from European drugs regulators, will be rolled out gradually in Africa, its maker said on Wednesday. "We believe that there should ...

Vaxine Pty Ltd - Product Pipeline Review - 2015

Recently added to the BioPortfolio report store, Vaxine Pty Ltd - Product Pipeline Review - 2015 is a new report from Global Markets Direct published on 2015-06-23. This 24-page report is available i...

Lipotek Pty Ltd. - Product Pipeline Review - 2015

Recently added to the BioPortfolio report store, Lipotek Pty Ltd. - Product Pipeline Review - 2015 is a new report from Global Markets Direct published on 2015-06-23. This 20-page report is available...

Escherichia Coli Infections - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Escherichia Coli Infections - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-06-23. This 156-page report is ava...

Ibrance, Prevnar 2Q sales validate Pfizer's R&D investments

Pfizer's investments in research and development paid off during the second quarter when the company generated $11.9bn in revenue, including better than expected sales for the new breast cancer drug I...

New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market

BANGALORE, July 29, 2015 /PRNewswire/ -- According to a new market research report, 'Global Therapeutic Vaccines Market - Growth, Trends & Forecasts (2015-2020)', published by Mordor Intelligence...

California lawmaker battles recall by anti-vaccine activists

SACRAMENTO, Calif. (Reuters) - The California lawmker who made it harder for parents to opt out of vaccinating their children, a stance that earned him death threats, is now launching a campaign to sa...

Closing the gap on developing a vaccine for middle ear infections

(Griffith University) Researchers in Australia and the US have made a discovery with the potential to impact the treatment of middle ear infections and other illnesses.

Sanofi Pasteur: Creating Vaccines, Protecting Lives

Sanofi Pasteur produce more than 1 billion doses of vaccines yearly to immunize more than 500 million people in the world. During BIO 2015, Roman Chicz Head of External R&D told PharmaVentures' Fintan...

Immune Response BioPharma, Inc. Posts First Half 2015 Results

New York, NY, July 28, 2015 --(PR.com)-- First Half 2015 Highlights: * IRBP met with the FDA in late March 2015 which resulted in a constructive path forward for the Remune HIV/AIDS vaccine FDA BLA....

Events [0 Results]

None

Companies [100 Associated Companies listed on BioPortfolio]

EY Laboratories inc

Manufacturer of biochemical reagents serving the needs of biochemical research in glycobiology, immunology, and microbiology. Manufacturer of rapid, simple, and stable diagnostic test kits for visual ...

Aduro BioTech, Inc.

Aduro BioTech is a clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. The platform of at...

ADC Therapeutics Sarl

ADC Therapeutics (ADCT) is a Swiss-based oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cance...

The Vaccine & Gene Therapy Institute of Florida (VGTI Florida)

Targovax

Targovax was started in October 2010 to develop TG01, a vaccine targeting pancreatic cancer. TG01 is based on research from The Radium Hospital and Norsk Hydro in the end of the 9...

Genocea Biosciences

Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development. The Company’s proprietary T cell-directed antigen disc...

The Vaccine & Gene Therapy Institute of Florida

ImmusanT Inc.

ImmusanT is a privately-held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

Affinivax Inc.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challengi...

Mucosis B.V.

Mucosis B.V. (Mucosis) is a clinical-stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious disea...

Clinical Trials [2275 Associated Clinical Trials listed on BioPortfolio]

Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma

The early clinical development paradigm for chemotherapeutic agents has significantly influenced the development of therapeutic cancer vaccines. However, there are major differences betwee...

A Pilot Study Comparing the Effectiveness of Campus Intervention to Increase HPV Vaccine Rate Among College Aged Men

This is a study testing what type of message and access influences a young male to get the HPV vaccine. The investigators are conducting a 2 X 2 design These conditions are: ...

Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects

Study AFF011 is a single blind, single-center, randomized, placebo-controlled, parallel group, phase I clinical trial of repeated administration by subcutaneous injection of a single dose ...

A Study to Evaluate the Efficacy of MEDI7510 in Older Adults

This study will be the first assessment of the efficacy of MEDI7510 for the prevention of RSV disease. It will also provide estimates of vaccine efficacy and of endpoint incidence in the p...

Multi-peptide CMV-MVA Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

This randomized phase II trial studies the safety and how well multi-peptide cytomegalovirus (CMV)-modified vaccinia Ankara (MVA) vaccine works in reducing CMV complications in patients pr...

Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy

Background and aims: Nucleos(t)ide analogues may suppress HBV DNA to undetectable level, but only about 30-40% remain sustained response 1-3 years after discontinued therapy. The investiga...

Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic

Tuberculosis (TB) is a global challenge and for the increasing epidemic of multi-drug resistant (MDR)-TB there is restricted treatment options. This calls for research of new immune-modula...

Speed of Injection and Pain During Routine Infant Vaccinations

Vaccine injections are a significant source of pain for infants. Altering the injection speed when administering vaccines may be an effective intervention and is feasible (cost neutral). A...

Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults

The study will evaluate the safety and immunogenicity of 3 consistency lots and a high-dose lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in healthy adults. The primary purpose of this study i...

Safety and Immunogenicity of a New Formulation of Euvichol®

- Number of doses and intervals: Two doses, 2 weeks apart - Method of administration: Oral administration - Volume of vaccine to be administered: 1.5 mL/dose - Observati...

Videos

None available.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)


Advertisement
 
Advertisement
 
review and buy Meningococcal Conjugates Vaccine market research data and corporate reports here

Channels Quicklinks